Approval sought for new PI.
D000328:Adult; D002648:Child; D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones / Q000494:pharmacology / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir